Publications
Detailed Information
National surveillance of antifungal susceptibility of Candida species in South Korean hospitals
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoo, Jae Il | - |
dc.contributor.author | Choi, Chi Won | - |
dc.contributor.author | Lee, Kyeong Min | - |
dc.contributor.author | Kim, Young Kwon | - |
dc.contributor.author | Kim, Eui-Chong | - |
dc.contributor.author | Yun, Seon Han | - |
dc.contributor.author | Kim, Bong Su | - |
dc.contributor.author | Lee, Yeong Seon | - |
dc.contributor.author | Joo, Sae Ik | - |
dc.contributor.author | Kim, Tae Un | - |
dc.date.accessioned | 2012-05-22T02:10:16Z | - |
dc.date.available | 2012-05-22T02:10:16Z | - |
dc.date.issued | 2009 | - |
dc.identifier.citation | MEDICAL MYCOLOGY; Vol.47 5; 554-558 | ko_KR |
dc.identifier.issn | 1369-3786 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76204 | - |
dc.description.abstract | We investigated the species distribution and antifungal susceptibility of Candida isolates from tertiary and non-tertiary hospitals in South Korea from 2002-2004. Of the 612 Candida isolates that were collected, Candida albicans, C. parapsilosis, C. tropicalis, and C. glabrata occurred most frequently, accounting for 97.3% and 96.8% of the isolates in tertiary and non-tertiary hospitals, respectively. C. albicans was the most common isolate, but the incidence of non-C. albicans Candida species was higher than that of C. albicans in tertiary hospitals. The Candida species had much lower MIC(90) to voriconazole (tertiary hospitals: 0.5 mu g/ml, non-tertiary hospitals: 0.25 mu g/ml) than to fluconazole (tertiary hospitals: 8 mu g/ml, non-tertiary hospitals: 4 mu g/ml). The MIC(90) of Candida isolates to 5-flucytosine in non-tertiary hospitals was two times higher than that observed in tertiary facilities. The C. glabrata isolates showed a tendency toward strong resistance to fluconazole, but C. parapsilosis isolates were susceptible to all of the evaluated antifungal agents. Voriconazole showed strong in vitro activity against Candida species, especially C. krusei, which is resistant to fluconazole and 5-flucytosine. To our knowledge, this is the first report of Candida antifungal susceptibility that includes non-tertiary hospitals in South Korea. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | TAYLOR & FRANCIS LTD | ko_KR |
dc.subject | Candida species | ko_KR |
dc.subject | non-tertiary hospitals | ko_KR |
dc.subject | tertiary hospitals | ko_KR |
dc.subject | antifungal susceptibility | ko_KR |
dc.title | National surveillance of antifungal susceptibility of Candida species in South Korean hospitals | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 유재일 | - |
dc.contributor.AlternativeAuthor | 최치원 | - |
dc.contributor.AlternativeAuthor | 이경민 | - |
dc.contributor.AlternativeAuthor | 김영관 | - |
dc.contributor.AlternativeAuthor | 김태운 | - |
dc.contributor.AlternativeAuthor | 김의종 | - |
dc.contributor.AlternativeAuthor | 주사익 | - |
dc.contributor.AlternativeAuthor | 윤선한 | - |
dc.contributor.AlternativeAuthor | 이영선 | - |
dc.contributor.AlternativeAuthor | 김봉수 | - |
dc.identifier.doi | 10.1080/13693780802354037 | - |
dc.citation.journaltitle | MEDICAL MYCOLOGY | - |
dc.description.citedreference | *CLIN LAB STAND I, 2006, M27S2 CLIN LAB STAND | - |
dc.description.citedreference | YANG YL, 2006, MED MYCOL, V22, P237 | - |
dc.description.citedreference | Nucci M, 2005, CLIN INFECT DIS, V41, P521, DOI 10.1086/432060 | - |
dc.description.citedreference | Takakura S, 2004, J ANTIMICROB CHEMOTH, V53, P283, DOI 10.1093/jac/dkh053 | - |
dc.description.citedreference | Cheng MF, 2004, DIAGN MICR INFEC DIS, V48, P33 | - |
dc.description.citedreference | FOONGLADDA S, 2004, J MED ASS THAI, V87, P92 | - |
dc.description.citedreference | BASU S, 2003, REV IBEROAM MICOL, V20, P137 | - |
dc.description.citedreference | Krcmery V, 2002, J HOSP INFECT, V50, P243, DOI 10.1053/jhin.2001.1151 | - |
dc.description.citedreference | Pfaller MA, 2002, J CLIN MICROBIOL, V40, P852, DOI 10.1128/JCM.40.3.852-856.2002 | - |
dc.description.citedreference | *CLIN LAB STAND I, 2002, M27A2 CLIN LAB STAND | - |
dc.description.citedreference | St-Germain G, 2001, J CLIN MICROBIOL, V39, P949, DOI 10.1128/JCM.39.3.949-953.2001 | - |
dc.description.citedreference | TOSCANO CM, 1999, CURR INFECT DIS REP, V1, P347, DOI 10.1007/s11908-999-0041-3 | - |
dc.description.citedreference | Pfaller MA, 1998, DIAGN MICR INFEC DIS, V31, P327 | - |
dc.description.citedreference | Marichal P, 1997, ANTIMICROB AGENTS CH, V41, P2229 | - |
dc.description.citedreference | RUHNKE M, 1994, J CLIN MICROBIOL, V32, P2092 | - |
dc.description.citedreference | BANERJEE SN, 1991, AM J MED, V91, pS86 | - |
dc.description.citedreference | RICHARDSON MD, 1991, J ANTIMICROB CHEMOTH, V28, P1 | - |
dc.description.tc | 2 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.